Market Tracker

12/19 11:01pm ET

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

0.47
Data as of Dec 19
 +0.005 / +1.08%
Today’s Change
0.33
Today|||52-Week Range
6.78
-92.26%
Year-to-Date

Today’s Trading

Previous close0.47
Today’s open0.45
Day’s range0.45 - 0.53
Volume427,971
Average volume (3 months)747,054
Market cap$16.8M
Dividend yield--
Data as of 4:00pm ET, 12/19/2014

Growth & Valuation

Earnings growth (last year)+39.13%
Earnings growth (this year)-14.29%
Earnings growth (next 5 years)--
Revenue growth (last year)+9.32%
P/E ratioNM
Price/Sales61.71
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RGDXResponse Genetics In...-0.01-1.15%
RTGNRuthigen Inc-0.00-0.14%
DARADARA BioSciences Inc+0.04+4.30%
OMBPOmni Bio Pharmaceuti...+0.05+12.82%
Data as of 4:00pm ET, 12/19/2014

Financials

Next reporting dateMarch 13, 2015
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$3.4M
Annual profit (last year)-$4.9M
Net profit margin-146.13%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer
André Monette
Corporate headquarters
Saint-Laurent, Quebec

Forecasts